OTC Markets OTCPK - Delayed Quote USD
Propanc Biopharma, Inc. (PPCB)
6.46
+0.96
+(17.45%)
At close: April 23 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| KENYON JULIAN NORMAN Officer and Director | Stock Award(Grant) | Aug 17, 2021 | 3,420,000 |
| NATHANIELSZ JAMES ANDREW Chief Executive Officer | Stock Award(Grant) | Aug 17, 2021 | -- |
Related Tickers
ENDV Endonovo Therapeutics, Inc.
0.0002
0.00%
KTTA Pasithea Therapeutics Corp.
1.6300
+5.84%
KZIA Kazia Therapeutics Limited
3.3250
-3.76%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.4200
+9.23%
GBLX GB Sciences, Inc.
0.0002
0.00%
CDT Conduit Pharmaceuticals Inc.
0.5565
-4.22%
VRTX.MX Vertex Pharmaceuticals Incorporated
9,360.00
0.00%
ARTH Arch Therapeutics, Inc.
0.1608
0.00%
MTEM Molecular Templates, Inc.
0.0001
0.00%
RADX Radiopharm Theranostics Limited
4.0500
-3.34%